SoundBite Medical Solutions Was Honored with the “Prix Genie innovation 2019” by the Order of Engineers of Quebec

MONTREAL – June 6, 2019 – SoundBite Medical Solutions Inc. (SBMS) today announced that Martin Brouillette, Cofounder & Chief Technology Officer, along with the SoundBite Team, was honored with the “Prix Genie innovation 2019” at the 15th “Soirée de l’Excellence en génie” on Wednesday, May 29, 2019, at Salon 1861 in Montréal.

The goal of the Prix Génie Innovation is to encourage innovative engineering by recognizing its value both in terms of the results achieved and the efforts made. This year the SoundBite Team was awarded this prize in recognition of the SoundBite system development, which represents a major innovative breakthrough in CTO treatment resulting in improved crossing success rate and patients’ quality of life.

“This award is the direct result of the efforts and dedication of our excellent team of employees, and we are honored to contribute to the visibility of Québec’s engineering expertise at home and abroad,” said Martin Brouillette.

About SoundBite Medical Solutions

SoundBite is a privately-held medical device company developing products in the field of vessel preparation for the management and treatment of calcified and occlusive lesions in coronary and peripheral arterial diseases. SoundBite will leverage its shock wave technology platform to clinically and commercially validate its calcium management medical devices with active wires and microcatheters. Peripheral artery disease (PAD) and coronary artery disease (CAD) affect more than 12 million & 16 million people in the US, respectively.

For additional information visit

For information on SoundBite Medical Solutions, please contact Mandy Di Lazzaro, Director, Human Resources & Communications ( or Francis Bellido, CEO (, SoundBite Medical Solutions, 2300 Alfred Nobel, Technoparc St-Laurent, Montreal Québec H4S 2A4

Forward-Looking Statements
This press release contains forward-looking statements and forward-looking information, or, collectively, forward-looking statements, within the meaning of applicable securities laws, that are based on our management’s belief and assumptions and on information currently available to our management. You can identify forward-looking statements by terms such as “may”, “will”, “should”, “could”, “would”, “outlook”, “believe”, “plan”, “envisage”, “anticipate”, “expect” and “estimate” or the negatives of these terms, or variations of them. Forward-looking statements are based upon a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond SoundBite Medical Solutions Inc.’s control that could cause actual results to differ materially from those that are disclosed in or implied by such forward-looking information. The reader is cautioned to consider these and other risks and uncertainties carefully and not to put undue reliance on forward looking statements. Forward-looking statements reflect current expectations regarding future events and speak only as of the date of this press release and represent our expectations as of that date. We undertake no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances.

SoundBite Admin